Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Anus Neoplasms - Pipeline Insight, 2024
... picture of the Anus Neoplasms pipeline landscape is provided, which includes the disease overview and Anus Neoplasms treatment guidelines. The assessment part of the report embraces in-depth Anus Neoplasms commercial assessment and clinical assessment of ... Read More
-
Astigmatism - Pipeline Insight, 2024
... pipeline landscape is provided, which includes the disease overview and Astigmatism treatment guidelines. The assessment part of the report embraces in-depth Astigmatism commercial assessment and clinical assessment of the Astigmatism pipeline products from the pre-clinical ... Read More
-
idiopathic Multicentric Castleman's disease (iMCD) - Pipeline Insight, 2024
... growth prospects across the idiopathic Multicentric Castleman's disease (iMCD) market. A detailed picture of the idiopathic Multicentric Castleman's disease (iMCD) pipeline landscape is provided, which includes the disease overview and idiopathic Multicentric Castleman's disease (iMCD) ... Read More
-
Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist - Pipeline Insight, 2024
... insights of the pipeline (under development) therapeutics scenario and growth prospects across Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) Antagonist development. The report provides detailed coverage of the pipeline landscape for this ... Read More
-
Nocturnal Enuresis - Pipeline Insight, 2024
... picture of the Nocturnal Enuresis pipeline landscape is provided, which includes the disease overview and Nocturnal Enuresis treatment guidelines. The assessment part of the report embraces in-depth Nocturnal Enuresis commercial assessment and clinical assessment of ... Read More
-
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024
... pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive ... Read More
-
Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024
... companies and 3+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
Potassium channel antagonists - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Insight, 2024
... growth prospects across the Secondary Progressive Multiple Sclerosis (SPMS) market. A detailed picture of the Secondary Progressive Multiple Sclerosis (SPMS) pipeline landscape is provided, which includes the disease overview and Secondary Progressive Multiple Sclerosis (SPMS) ... Read More
-
5-HT4 Partial Agonist - Pipeline Insight, 2024
... The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. ... Read More
-
5-HT7 Antagonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Chronic Progressive Multiple Sclerosis - Pipeline Insight, 2024
... the Chronic Progressive Multiple Sclerosis market. A detailed picture of the Chronic Progressive Multiple Sclerosis pipeline landscape is provided, which includes the disease overview and Chronic Progressive Multiple Sclerosis treatment guidelines. The assessment part of ... Read More
-
5-HT2C Agonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
2024 Global Computer-Aided Drug Discovery Market Industry (2030 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include ... Read More
-
TGF-Beta-2 Inhibitor - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Transitional Cell Carcinoma - Pipeline Insight, 2024
... Carcinoma market. A detailed picture of the Transitional Cell Carcinoma pipeline landscape is provided, which includes the disease overview and Transitional Cell Carcinoma treatment guidelines. The assessment part of the report embraces in-depth Transitional Cell ... Read More
-
30S Ribosomal Subunit (30S RNA) Inhibitor - Pipeline Insight, 2024
... prospects across 30S Ribosomal Subunit (30S RNA) Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental ... Read More
-
5-HT2 Agonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Thyroid eye disease - Pipeline Insight, 2024
... disease market. A detailed picture of the Thyroid eye disease pipeline landscape is provided, which includes the disease overview and Thyroid eye disease treatment guidelines. The assessment part of the report embraces in-depth Thyroid eye ... Read More
-
5-HT1 Antagonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
5-HT1D Agonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
5-HT4 Agonist - Pipeline Insight, 2024
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Topical Skin Infection Treatment - Pipeline Insight, 2024
... the Topical Skin Infection Treatment market. A detailed picture of the Topical Skin Infection Treatment pipeline landscape is provided, which includes the disease overview and Topical Skin Infection Treatment treatment guidelines. The assessment part of ... Read More
-
Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist - Pipeline Insight, 2024
... 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist development. The report ... Read More
-
Personalized Medicine Market Report by Product (Personalized Medicine Therapeutics, Personalized Medicine Diagnostics, Personalized Medical Care, and Personalized Nutrition and Wellness), Application (Oncology, Infectious disease, Neurology or Psychiatry, Cardiovascular, and Others), End-Users (Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others), Region and Company Analysis 2024-2032
... & Academic Institutes, and Others), Region and Company Analysis 2024-2032 The global personalized medicine market was worth US$ 511.09 billion in 2023 and is expected to grow at a CAGR of 7.02% from 2024 to ... Read More
Research Assistance
